Oral drug for multiple sclerosis significantly reduces disease activity and slows disability, study suggests
Monday, April 11, 2011 - 23:30
in Health & Medicine
The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study.